Micrographia Bio

Micrographia Bio is a biotechnology company developing a spatial proteomics platform for drug discovery.

Its technology combines highly multiplexed microscopy with machine-intelligent computer vision to autonomously determine the mechanism of action of therapeutic candidates by visualising protein-protein interactions in their cellular spatial context.

The company serves pharmaceutical and biotechnology researchers and is advancing an internal pipeline of therapeutic candidates targeting fundamental cellular pathways.